Sort
15,842 grants matching “pancreatic cancer”
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
$304,278Guang-Yu Yang · Northwestern University At Chicago · R01 · FY2013 · CA
The Role of Myc in ChREBP-dependent, Glucose-stimulated Gene Expression
$304,237Donald K Scott · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · DK
Project 2: Targeting Immune Vulnerabilities in Lung Cancer
$304,170John V. Heymach · Ut Southwestern Medical Center · P50 · FY2020 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$304,169Johns Hopkins University · U10 · FY2001 · CA
Development of a gold nanoparticles based targeted delivery system
$304,127Priyabrata Mukherjee · Mayo Clinic Rochester · R01 · FY2012 · CA
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
$304,127Richard G Vile · Mayo Clinic Rochester · R01 · FY2012 · CA
Pharmacogenomics and Mechanisms of Cytidine Analogues
$304,127Liewei Wang · Mayo Clinic Rochester · R01 · FY2012 · CA
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
$304,127Richard G Vile · Mayo Clinic Rochester · R01 · FY2011 · CA
Development of a gold nanoparticles based targeted delivery system
$304,127Priyabrata Mukherjee · Mayo Clinic Rochester · R01 · FY2011 · CA
Pharmacogenomics and Mechanisms of Cytidine Analogues
$304,127Liewei Wang · Mayo Clinic Rochester · R01 · FY2011 · CA
Structural Biology Shared Facility
$304,124Lawrence J Delucas · University Of Alabama At Birmingham · P30 · FY2017 · CA
RO1: A novel and targeted approach to inhibit invasion and angiogenesis
$304,000Fazlul H. Sarkar · Wayne State University · R01 · FY2009 · CA
Chromatin targeting and transcriptional control by the histone variant H2A.Z
$303,996Roger Bancroft Deal · Emory University · R01 · FY2022 · GM
Digestive Diseases Training Program
$303,962University Of Pittsburgh At Pittsburgh · T32 · FY2005 · DK
Nanostructured Matrices for Cancer Cell Biology
$303,940Milan Mrksich · Northwestern University At Chicago · U54 · FY2010 · CA
Mechanisms of TLR-mediated prevention of transplantation tolerance
$303,930Maria-Luisa Alegre · University Of Chicago · R01 · FY2010 · AI
Novel Nanoparticle Therapy for Pancreatic Cancer
$303,857Gail L. Matters · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · CA
Basic Science Research in Digestive Diseases
$303,847Mark Donowitz · Johns Hopkins University · T32 · FY2016 · DK
Identifying and Targeting Pathways of Pancreatic Cancer Progression
$303,746David Andrew Largaespada · University Of Alabama At Birmingham · P50 · FY2010 · CA
Markers for Screening and Prognosis
$303,700Michael G. Goggins · Johns Hopkins University · P50 · FY2013 · CA
Enhancing immune therapy in pancreatic cancer by targeting IL-6
$303,623Gregory B. Lesinski · Emory University · R01 · FY2021 · CA
Combination therapy using tumor-targeting synthetic dsRNA and gemcitabine
$303,617Zhengrong Cui · University Of Texas At Austin · R01 · FY2010 · CA
P-4: Direct Delivery of Immune-modulating Therapies to the Pancreatic Tumor Site
$303,584Pinku Mukherjee · Mayo Clinic Rochester · P50 · FY2008 · CA
RIBONUCLEASES IN CANCER CHEMOTHERAPY
$303,569Ronald T Raines · University Of Wisconsin-Madison · R01 · FY2007 · CA
DPC4 TARGET OF 18Q HOMOZYGOUS DELETIONS IN PANCREATIC CA
$303,522Johns Hopkins University · R01 · FY2000 · CA